Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Robert S. Svatek

Urology
UT Health San Antonio
The University Of Texas Health Science Center At San Antonio
7703 Floyd Curl Dr, Suite Mc7977, 
San Antonio, TX 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
UT Health San Antonio
The University Of Texas Health Science Center At San Antonio
7703 Floyd Curl Dr, Suite Mc7977, 
San Antonio, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Svatek is an Urologist in San Antonio, Texas. Dr. Svatek is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Svatek is currently accepting new patients.

His clinical research consists of co-authoring 159 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in TX
Hospital Affiliations
Christus Santa Rosa Medical Center
University Health System
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Community First Health Plans
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO
7703 Floyd Curl Dr, Suite Mc7977, San Antonio, TX 78229
Call: 210-450-9000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

Phase II Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Phase II Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Enrollment Status: Recruiting
Publish Date: May 15, 2025
Intervention Type: Drug
Study Drug: Encapsulated Rapamycin
Study Phase: Phase 2
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2025
Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design (STRATA Study)
Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design (STRATA Study)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
Enrollment Status: Completed
Publish Date: June 14, 2021
Intervention Type: Other
A Randomized Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
A Randomized Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: March 19, 2021
Intervention Type: Drug
Study Drug: Rapamycin
Study Phase: Early Phase 1
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
Enrollment Status: Withdrawn
Publish Date: June 12, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

159 Total Publications

Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group.
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group.
Journal: European urology oncology
Published: May 13, 2025
View All 159 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. William J. Harmon
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. William J. Harmon
Urology

Urology San Antonio P A

7909 Fredericksburg Rd, Suite 135, 
San Antonio, TX 
 (0.5 miles away)
210-731-2050
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

William Harmon is an Urologist in San Antonio, Texas. Dr. Harmon is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Harmon is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael A. White
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael A. White
Urology

Urology San Antonio P A

18915 Meisner Dr, Urology San Antonio, 
San Antonio, TX 
 (9.5 miles away)
210-499-5158
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael White is an Urologist in San Antonio, Texas. Dr. White is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Chromophobe Renal Cell Carcinoma, Ureteral Reconstruction, and Reconstructive Urology Surgery. Dr. White is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kenneth J. Stallman
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kenneth J. Stallman
Urology

Urology San Antonio P A

7909 Fredericksburg Rd, Suite 125, 
San Antonio, TX 
 (0.5 miles away)
210-731-2050
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Kenneth Stallman is an Urologist in San Antonio, Texas. Dr. Stallman is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Congenital Mesoblastic Nephroma, Reconstructive Urology Surgery, and Nephrectomy. Dr. Stallman is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Svatek's expertise for a condition
ConditionClose
  • Elite
  • Bladder Cancer
    Dr. Svatek is
    Elite
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Cystectomy
    Dr. Svatek is
    Elite
    . Learn about Cystectomy.
    See more Cystectomy experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Svatek is
    Elite
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
  • Urothelial Cancer
    Dr. Svatek is
    Elite
    . Learn about Urothelial Cancer.
    See more Urothelial Cancer experts
  • Distinguished
  • Muscle Invasive Bladder Cancer
    Dr. Svatek is
    Distinguished
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Advanced
  • Intussusception in Children
    Dr. Svatek is
    Advanced
    . Learn about Intussusception in Children.
    See more Intussusception in Children experts
  • Lymphadenectomy
    Dr. Svatek is
    Advanced
    . Learn about Lymphadenectomy.
    See more Lymphadenectomy experts
  • Malakoplakia
    Dr. Svatek is
    Advanced
    . Learn about Malakoplakia.
    See more Malakoplakia experts
  • Nephrectomy
    Dr. Svatek is
    Advanced
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Obstructive Uropathy
    Dr. Svatek is
    Advanced
    . Learn about Obstructive Uropathy.
    See more Obstructive Uropathy experts
  • Reconstructive Urology Surgery
    Dr. Svatek is
    Advanced
    . Learn about Reconstructive Urology Surgery.
    See more Reconstructive Urology Surgery experts
View All 8 Advanced Conditions
  • Experienced
  • Acute Cystitis
    Dr. Svatek is
    Experienced
    . Learn about Acute Cystitis.
    See more Acute Cystitis experts
  • Bilateral Hydronephrosis
    Dr. Svatek is
    Experienced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Bladder Reconstruction
    Dr. Svatek is
    Experienced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Boils
    Dr. Svatek is
    Experienced
    . Learn about Boils.
    See more Boils experts
  • Carbuncle
    Dr. Svatek is
    Experienced
    . Learn about Carbuncle.
    See more Carbuncle experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Svatek is
    Experienced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved